Daclatasvir Tablets

Get a Price/Quote

Daclatasvir Tablets Trade Information

Minimum Order Quantity
100 box

Payment Terms
Paypal, Letter of Credit (L/C), Western Union, Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)

Delivery Time
30 Days

Sample Policy
Within a certain price range free samples are available

Main Export Market(s)
Australia, Eastern Europe, Western Europe, Africa, Middle East, Asia

Certifications
ISO, GMP, WHO

About Daclatasvir Tablets

We Rewine Pharmaceutical are a leading Manufacturer and Exporter of DACLAHEL 60mg (Daclatasvir 60mg) Tablets in different strength and packing. Our manufacturing facility is certified with WHO-GMP.

COMPOSITION :

Daclacure 60mg (Daclatasvir 60mg )Tablets

Brand name: DACLAHEL
Active Ingeridents(Generic Name) : Daclatasvir 60mg
Company Name: Hetero
Strength : 60 mg
Package: 28 tabs
Pack Type : Bottle

Indication:

DACLAHEL 60mg (Daclatasvir 60mg )Tablets
is an inhibitor of non-structural protein 5A (NS5A). Each film coated tablet contains Daclatasvir Dihydrochloride equivalent to Daclatasvir 60 mg. Daclatasvir is white to yellow colour solid and freely soluble in water. Daclatasvir is prescribed for the treatment of patients with chronic HCV genotype 3 infections along with Sofosbuvir 400mg tablets. Daclatasvir has revolutionized the management of HEPATITIS C by offering Ribavirin and Peg-free treatment for all the genotypes of Hepatitis C.

Uses:- DACLAHEL 60mg (Daclatasvir 60mg )Tablets
is indicated for use, with sofosbuvir, for the treatment of patients with chronic HCV genotype 3. For patients without cirrhosis the recommended treatment course is 12 weeks. For patients with cirrhosis, the optimal dosing duration of therapy is not known. Use of daclatasvir is contraindicated for use with drugs that are strong inducers of CYP3A

Available other Brand: Natdac, mydacla, Hepcfix, Declahep

Advanced Hepatitis C Treatment

Daclatasvir Tablets provide reliable antiviral therapy for those diagnosed with hepatitis C. The formulation is effective across multiple age groups and is accessible for both adult men and women. Manufactured in India, the product adheres to international pharmaceutical standards, ensuring safety and consistent performance.

Safe Storage for Maximum Potency

To retain the full therapeutic benefits, Daclatasvir Tablets must be stored in a cool environment. Proper storage not only preserves the medications effectiveness but also prolongs shelf life. User compliance with storage guidelines is essential for optimal outcomes during the course of treatment.

FAQs of Daclatasvir Tablets:

Q: How should Daclatasvir Tablets be stored for best results?

A: Daclatasvir Tablets must be kept in a cool environment. Avoid exposing them to high temperatures, humidity, or direct sunlight as these conditions may compromise the medications effectiveness.

Q: What is the recommended age and gender usage for Daclatasvir Tablets?

A: These tablets are suitable for adults and women, and their formulation is safe and effective for all ages within the adult category. Always consult a health professional for individual recommendations.

Q: When is the best time to take Daclatasvir during hepatitis C treatment?

A: Daclatasvir should be taken consistently at the same time each day, as directed by your healthcare provider, in order to maintain stable blood levels and optimize treatment success.

Q: Where are Daclatasvir Tablets manufactured and exported from?

A: Daclatasvir Tablets are manufactured, supplied, and exported from India by licensed pharmaceutical companies, ensuring high quality and compliance with international standards.

Q: What is the process to obtain Daclatasvir Tablets for export or supply?

A: To obtain Daclatasvir Tablets for export or supply, contact certified manufacturers or suppliers in India. They can provide documentation and regulatory support for international orders.

Q: How do Daclatasvir Tablets benefit hepatitis C patients?

A: Daclatasvir Tablets significantly inhibit the viruss replication, reducing viral load and improving liver function, which enhances prognosis in hepatitis C patients.

Tell us about your requirement